Innovating Works

ACS

A stranger
EuroNeurotrophin: A European training network for the discovery of neurotrophins small molecule mimetics as candidate... AvantiCell Science Ltd participó en un H2020 H2020-MSCA-ITN-2017 Neurodegenerative diseases (ND) like AD, PD, MS and ALS/MND are on the rise in developed societies worldwide. Currently, there exists no cu...
2017-08-17 - 2022-03-31 | financed
CENSUS: Cell Based Models for Neurodegeneration Study and Use in Screening AvantiCell Science Ltd processed a H2020 H2020-FTIPilot-2016 1. Treatment of neurodegenerative disease is an unmet clinical challenge and patient care is a growing, unsustainable global healthcare burd...
2016-09-13 - 2019-09-30 | financed
TRANSMIT: TRANSlating the role of Mitochondria in Tumorigenesis AvantiCell Science Ltd participó en un H2020 H2020-MSCA-ITN-2016 The consolidation of the knowledge that cancer is not only a genetic, but also a metabolic disease, has led scientists to investigate the in...
2016-08-16 - 2021-06-30 | financed
ANAPRINT: Additive Printing for Cell Based Analysis AvantiCell Science Ltd processed a H2020 H2020-SMEInst-2014-2015 The Project shall develop a unique manufacturing solution for the automated production of complex cell models widely used by industry to tes...
2015-10-11 - 2018-10-31 | financed
PANDORA: Probing safety of nano objects by defining immune responses of environmental organisms AvantiCell Science Ltd participó en un H2020 H2020-MSCA-ITN-2015 PANDORA (Probing safety of nano-objects by defining immune responses of environmental organisms) shall assess the global impact of engineere...
2015-08-10 - 2019-12-31 | financed
Chromatin3D: Chromatin Dynamics in Development and Disease AvantiCell Science Ltd participó en un H2020 H2020-MSCA-ITN-2014 The cell nucleus is organized and compartmentalized into a highly ordered structure that contains DNA, RNA, chromosomal and histone proteins...
2014-12-12 - 2018-12-31 | financed
ANAPRINT: Additive Printing for Cell based Analysis AvantiCell Science Ltd processed a H2020 H2020-SMEInst-2014-2015 The Project will develop and commercialise the additive printing of cell-based analysis systems. The objective is to deliver consistent, sca...
2014-09-15 - 2015-03-31 | financed
PathChooser: Innovative mechanistic based strategies for delivery of therapeutic macromolecules across cellular... AvantiCell Science Ltd participó en un FP7 Nanomedicine offers capability to significantly change the course of treatment for life-threatening diseases. Many of the most significant c...
financed
MAGISTER: Magnetic Scaffolds for in vivo Tissue Engineering AvantiCell Science Ltd participó en un FP7 The main driving idea of the project is the creation of conceptually new type of scaffolds able to be manipulated in situ by means of magnet...
financed
NEXT: Nano Engineering for Cross Tolerance new approach for bioengineered vascularised chimeric islet t... AvantiCell Science Ltd participó en un FP7 Diabetes is caused by insufficient or lack of insulin secretion by the specialized B cells of the pancreas and, if not treated adequately ev...
financed
HUMUNITY: Cell Based Models of Human Mucosal Immunity with Multiple Commercial Applications AvantiCell Science Ltd participó en un FP7 HUMUNITY is a PhD school which shall train young scientists in novel approaches to the study of human mucosal immunity by the use of advance...
financed
NANOTOES: Nanotechnology Training Of Experts in Safety AvantiCell Science Ltd participó en un FP7 Life Sciences and Nano Sciences interact today mainly in two areas: in the evaluation of accidental health and environmental effects derived...
financed
BIOSID: A bioartificial pancreas to treat type 1 diabetes optimization of cell survival and function in pre... AvantiCell Science Ltd participó en un FP7 MAILPAN (MAcroencapsulation of PANcreatic Islets) is a prototype of bioartificial pancreas usable in the human designed to treat type 1 diab...
financed
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.